Trials / Recruiting
RecruitingNCT06725459
NPWT Reduction Mammaplasty
Assessing the Application of Closed Incision Negative Pressure Wound Therapy to Reduction Mammaplasty
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- Medstar Health Research Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this prospective, randomized, split-body control trial, we aim to compare complications, patient-reported outcomes, and cost differentials following reduction mammaplasty with prophylactic closed incision negative pressure wound therapy versus standard adhesive dressing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Prophylactic ciNPWT | The prophylactic closed incision negative pressure wound therapy (ciNPWT) will be applied to one breast for up to 7 days postoperatively to promote wound healing and prevent complications. |
| OTHER | Standard Adhesive Dressing | The standard adhesive strip dressing will be applied to one breast immediately after surgery. It provides a protective covering for the wound during the initial healing phase and is the standard of care for incision management. |
Timeline
- Start date
- 2024-12-17
- Primary completion
- 2026-07-01
- Completion
- 2026-11-01
- First posted
- 2024-12-10
- Last updated
- 2025-10-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06725459. Inclusion in this directory is not an endorsement.